Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Molbio Diagnostics Limited

Molbio Diagnostics Limited (MOLBIO.NS) Stock Overview

Explore Molbio Diagnostics Limited’s financial performance, market position, analyst ratings, and future outlook.

MOLBIO.NS●NSE
HealthcareMedical - Specialties
₹1288.30
₹3.00(0.23%)
Indian Market opens in 6h 49m

Molbio Diagnostics Limited (MOLBIO.NS)

Meyka AI Score

Z

Key Financials

Market Cap161.4B
P/E RatioN/A
EPS (TTM)$11.58
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$1428.56
3 Months$4934.49
1 Year TargetN/A

MOLBIO.NS Stock Analysis & Investment Overview (NSE)

Our AI-powered analysis of Molbio Diagnostics Limited (NSE: MOLBIO.NS) gives investors deep insight into how the stock performs on the NSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Molbio Diagnostics Limited's NSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MOLBIO.NS on the NSE shows an RSI of 56.71, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $N/A for the NSE listing.

Key metrics behind Molbio Diagnostics Limited's NSE-traded stock include a P/E ratio of N/A and a market capitalization of 161.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MOLBIO.NS on the NSE.

Price Performance (NSE: MOLBIO.NS)

1-Day Change
0.23%
5-Day Change
-16.61%
1-Month Change
15.97%
3-Month Change
59.64%
6-Month Change
59.64%
Year-to-Date (YTD) Change
59.64%
1-Year Change
59.64%
3-Year Change
59.64%
5-Year Change
59.64%
All-Time (Max) Change
59.64%

Contact Information

https://www.molbiodiagnostics.com
NaN
Plot No. L-46, Verna, GO, 403722

Company Facts

12,250 Employees
IPO DateAug 17, 2026
CountryIN
Actively Trading

Frequently Asked Questions